"Prions are proteins gone rogue. This is a small victory in our war against Prions," says Amprion CE
Read More
Today, the U.S. Food and Drug Administration permitted marketing of the Synovasure Lateral Flow Test
Read More
With a potential approval of an opioid molecule awaiting regulatory review, Nektar Therapeutics anno
Read More
Shares of Illinois-based Aptinyx have plunged more than 67 percent in premarket trading after the co
Read More
The decision comes ahead of data readouts for two of the clinical candidates – mavacamten and MYK-49
Read More
Privately-held Tizona Therapeutics snagged $105 million in upfront cash as its cancer antibody TTX-0
Read More
Days ahead of the J.P. Morgan Healthcare Conference, Germany-based BioNTech extended its three-year-
Read More